SCHEMBL4618665

SCHEMBL4618665

Cc1cnc(-c2ccc(Cl)cc2Cl)n1-c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.55
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.46
PKM P14618 1/20 0.46
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
PTGER1 P34995 8/20 0.45
BACE1 P56817 1/20 0.44
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
S1PR2 O95136 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
XBP1 P17861 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4563366 0.82 KMT2A (0.54) CNR1MEN1KMT2A
SCHEMBL3080647 0.79 CNR1 (0.74) CNR1NPC1RAB9AL3MBTL1
SCHEMBL12064374 0.77 CNR1 (0.47) CNR1MEN1KMT2A
SCHEMBL12064305 0.76 POLB (0.43) CNR1KDM4EMEN1KMT2A
SCHEMBL3093294 0.76 CNR1 (0.70) CNR1
SCHEMBL4903575 0.74 CNR1 (0.70) CNR1
SCHEMBL4904252 0.74 CNR1 (0.66) CNR1
SCHEMBL3683921 0.73 KMT2A (0.52) CNR1ALDH1A1MEN1KMT2AGAA
SCHEMBL12064373 0.73 ROS1 (0.46) PKMALDH1A1KDM4ELMNAMAPT
SCHEMBL14478865 0.72 RAB9A (0.61) NPC1RAB9AL3MBTL1SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940803-A1 1,2-DIARYLIMIDAZOLES FOR USE AS CBI MODULATORS AstraZeneca AB (SE) 2008-07-09 EP disclosed
WO-2007031720-A1 1,2-DIARYLIMIDAZOLES FOR USE AS CBI MODULATORS ASTRAZENECA AB (SE) 2007-03-22 WO disclosed